657 related articles for article (PubMed ID: 9736458)
1. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line.
Hofbauer LC; Hicok KC; Khosla S
J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458
[TBL] [Abstract][Full Text] [Related]
2. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
Hofbauer LC; Ten RM; Khosla S
J Bone Miner Res; 1999 Aug; 14(8):1330-7. PubMed ID: 10457265
[TBL] [Abstract][Full Text] [Related]
3. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
5. Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro.
Kasperk CH; Wakley GK; Hierl T; Ziegler R
J Bone Miner Res; 1997 Mar; 12(3):464-71. PubMed ID: 9076590
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
Wiren KM; Toombs AR; Semirale AA; Zhang X
Bone; 2006 May; 38(5):637-51. PubMed ID: 16413235
[TBL] [Abstract][Full Text] [Related]
7. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line.
Gori F; Hofbauer LC; Conover CA; Khosla S
Endocrinology; 1999 Dec; 140(12):5579-86. PubMed ID: 10579321
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene.
Hofbauer LC; Hicok KC; Schroeder MJ; Harris SA; Robinson JA; Khosla S
J Cell Biochem; 1997 Sep; 66(4):542-51. PubMed ID: 9282332
[TBL] [Abstract][Full Text] [Related]
10. Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells.
Hickey TE; Marrocco DL; Amato F; Ritter LJ; Norman RJ; Gilchrist RB; Armstrong DT
Biol Reprod; 2005 Oct; 73(4):825-32. PubMed ID: 15972887
[TBL] [Abstract][Full Text] [Related]
11. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
13. Both direct and collagen-mediated signals are required for active vitamin D3-elicited differentiation of human osteoblastic cells: roles of osterix, an osteoblast-related transcription factor.
Maehata Y; Takamizawa S; Ozawa S; Kato Y; Sato S; Kubota E; Hata R
Matrix Biol; 2006 Jan; 25(1):47-58. PubMed ID: 16266799
[TBL] [Abstract][Full Text] [Related]
14. 1,25(OH)2D3 and dihydrotestosterone interact to regulate proliferation and differentiation of epiphyseal chondrocytes.
Krohn K; Haffner D; Hügel U; Himmele R; Klaus G; Mehls O; Schaefer F
Calcif Tissue Int; 2003 Oct; 73(4):400-10. PubMed ID: 12874696
[TBL] [Abstract][Full Text] [Related]
15. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2.
Chung CY; Iida-Klein A; Wyatt LE; Rudkin GH; Ishida K; Yamaguchi DT; Miller TA
Biochem Biophys Res Commun; 1999 Nov; 265(1):246-51. PubMed ID: 10548521
[TBL] [Abstract][Full Text] [Related]
16. [Interaction effects between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta1 on the proliferation and differentiation of human embryonic osteoblasts].
Pei Y; Zhou XY; Meng XW; Xia WB; Xing XP; Liu HC; Hu YY
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(12):1084-8. PubMed ID: 12899784
[TBL] [Abstract][Full Text] [Related]
17. Estrogen regulation of a transforming growth factor-beta inducible early gene that inhibits deoxyribonucleic acid synthesis in human osteoblasts.
Tau KR; Hefferan TE; Waters KM; Robinson JA; Subramaniam M; Riggs BL; Spelsberg TC
Endocrinology; 1998 Mar; 139(3):1346-53. PubMed ID: 9492071
[TBL] [Abstract][Full Text] [Related]
18. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
[TBL] [Abstract][Full Text] [Related]
19. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
20. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
